Discover
SKYE
Skye Bioscience, Inc.
0.68
2 x 0.49
2 x 0.90
bid
ask
-
0.02
2.61%
2 @ 04:00 PM
0.69 +0.01 (2.00%)
| Ytd | -9.97% | |
| 1y | -81.95% |
0.68
day range
0.70
0.57
52 week range
4.99
| Open | 0.69 | Prev Close | 0.69 | Low | 0.68 | High | 0.70 | Mkt Cap | 23.73M |
| Vol | 61.33K | Avg Vol | 183.68K | EPS | -1.45 | P/E | N/A | Forward P/E | -2.27 |
| Beta | 1.75 | Short Ratio | 10.06 | Inst. Own | 86.03% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 0.80 | 200-d Avg | 1.20 | 1yr Est | 18.00 |
| Income Statement | |||
| Operating Expenses | 12.67M | ||
| Research and Development Expense | 7.94M | ||
| Selling, General and Administrative Expense | 4.74M | ||
| Operating Income | -12.67M | ||
| Interest Expense | 2.20K | ||
| Net Income | -12.51M | ||
| Net Income Common Stock | -12.51M | ||
| Net Income Common Stock (USD) | -12.51M | ||
| Consolidated Income | -12.51M | ||
| Earnings per Basic Share | -0.32 | ||
| Earnings per Basic Share (USD) | -0.32 | ||
| Earnings per Diluted Share | -0.32 | ||
| Earning Before Interest & Taxes (EBIT) | -12.51M | ||
| Earning Before Interest & Taxes (USD) | -12.51M | ||
| Weighted Average Shares | 39.68M | ||
| Weighted Average Shares Diluted | 39.68M | ||
| Balance Sheet | |||
| Cash and Equivalents | 8.15M | ||
| Cash and Equivalents (USD) | 8.15M | ||
| Investments | 8.96M | ||
| Investments Current | 8.96M | ||
| Current Assets | 18.57M | ||
| Property, Plant & Equipment Net | 813.86K | ||
| Total Assets | 19.42M | ||
| Debt Current | 311.32K | ||
| Total Debt | 311.32K | ||
| Current Liabilities | 10.40M | ||
| Total Liabilities | 10.40M | ||
| Accumulated Retained Earnings (Deficit) | -199.38M | ||
| Shareholders Equity | 9.01M | ||
| Shareholders Equity (USD) | 9.01M | ||
| Assets Non-Current | 849.77K | ||
| Total Debt (USD) | 311.32K | ||
| Trade and Non-Trade Payables | 3.94M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 172.89K | ||
| Net Cash Flow from Financing | -71.53K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 2.27M | ||
| Net Cash Flow - Business Acquisitions and Disposals | 850.00 | ||
| Issuance (Repayment) of Debt Securities | -71.53K | ||
| Net Cash Flow from Investing | 10.90M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 10.90M | ||
| Net Cash Flow from Operations | -8.56M | ||
| Share Based Compensation | 1.50M | ||